Bibliografía del artículo
1. WHO Classification of Tumours. Tumours of the breast and female genital organs. IARC Press. Lyon, 2003.
2. Wilkinson N, Rollason TP. Recent advances in the pathology of smooth muscle tumours of the uterus. Histopathology 39:331-341, 2001.
3. Rush DS, Tan J, Baergen RN, Soslow RA. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 25:253-258, 2001.
4. Nucci MR, O'Connell JT, Huettner PC, Cviko A, Sun D, Quade BJ. h-Caldesmon expression effectively distinguishes endometrial stromal tumours from uterine smooth muscle tumours. Am J Surg Pathol 25:455-463, 2001.
5. Zaloudek CJ, Norris HJ. Mesenchymal tumours of the uterus. Progress in Surgical Pathology 3:1-35, 1981.
6. O'Connor D, Norris HJ. Mitotically active leiomyomas of the uterus. Hum Pathol 21:223-227, 1990.
7. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18:535-558, 1994.
8. Dgani R, Piura B, Ben-Baruch G, Open M, Glezerman M, Nass D et al. Clinical-pathological study of uterine leiomyomas with high mitotic activity. Acta Obstet Gynecol Scand 77:74-77, 1998.
9. Prayson RA, Hart WR. Mitotically active leiomyomas of the uterus. Am J Clin Pathol 97:14-20, 1992.
10. Esteban JM, Allen WM, Schaerf RH. Benign metastasizing leiomyoma of the uterus. Arch Pathol Lab Med 123(10):960-2, 1999.
11. Forsnes EV, Derrough KR, O'Donnoghue M. A mitotically active myoma in Rokitansky-Kuster-Hauser syndrome. Obstet Gynecol 94:862, 1999.
12. Hejmadi RK, Ganesan R, Todd RW, Rollason TP. Mitotically active cervical leiomyoma in a non-HIV inmunosuppressed case. BJOG 110(12):1135-6, 2003.
13. Rammeh-Romani S, Mokni M, Stita W, Trabelsi A, Hamissa S, Sriha B et al. Uterine smooth muscle tumours: retrospective epidemiological and pathological study of 2760 cases. J Gynecol Obstet Biol Reprod (Paris) 34:568-571, 2005.